Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Coltene Holding AG is a Switzerland-based company specializing in the development, manufacture, and sale of consumables, disposables, tools, and small equipment for dentists and dental laboratories worldwide. Headquartered in Altstätten, it serves markets across Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania, targeting the dynamic CHF 14.4 billion dental consumables segment within the broader CHF 23.9 billion global dental market. The company offers comprehensive product lines spanning six key areas: endodontics with root canal files, rinsing solutions, obturation systems, and endo motors; restorative fillings including composites, adhesives, etching gels, and curing lights; prosthetics featuring impression materials like A-silicones and retractions; treatment auxiliaries such as dental dams, scalers, and aspirator tips; infection control products including ultrasonic cleaners and disinfectants; and rotary instruments like diamond burs and polishers. Coltene Holding AG pursues an 'Upgrade Dentistry' mission, innovating to enhance treatment efficiency, safety, and reliability in practices and labs through acquisitions and partnerships that bolster its technological edge and geographic presence. With around 1,176 employees, it focuses on demographic-driven growth, rising dental health awareness, and expanding access in emerging markets.
Operating margin is thin at 8.75%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 4.0% YoY. The question is whether this is cyclical or a structural shift.
Free cash flow declined 66% versus the prior year, cash generation momentum has weakened. ROIC dropped from 14.27% to 11.48%, capital efficiency is deteriorating.
Profitability & Returns
Revenue (TTM)
CHF 240M
▼ -4.0% YoY
Net Income (TTM)
CHF 15M
▼ -27.0% YoY
Op. Margin
8.75%
▼ -2.0pp YoY
ROIC
11.48%
▼ -2.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
CHF 8M
▼ -66.3% YoY
Op. Cash Flow (TTM)
CHF 11M
▼ -59.5% YoY
Net Debt
CHF 26M
Cash & Equiv.
CHF 21M
3Y CAGR: -3.5%
3Y CAGR: -20.1%
Continue Research